AURKA and neoplasm: Interestingly, the Aurora-A kinase polymorphism (Phe31/Ile) was significantly associated with tumor recurrence, and risk of death, and disease-free survival in ESCC [42] According to these reports, it is support our conclusion that abnormal Aurora-A expression promotes the development of tumor cells and clinical aggressiveness in HNSCC.